BRADLEY EILERMAN: Open Payments
NPI 1841389822 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275,326 in 424 payments from 39 companies in 2025. Trend: 2023 $116,220 · 2024 $230,252 · 2025 $275,326
Speaker / faculty: $195,355Travel & lodging: $28,926Honoraria: $16,286Consulting: $14,070Speaker / faculty: $13,446Food & beverage: $7,243
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 128 | $146,974 |
| Lilly USA, LLC | 111 | $85,007 |
| Novo Nordisk Inc | 43 | $14,253 |
| Dexcom, Inc. | 14 | $10,847 |
| RECORDATI_RARE_DISEASES_INC. | 14 | $6,636 |
| Novo Nordisk AS | 5 | $5,936 |
| Abbott Laboratories | 23 | $3,833 |
| SANOFI-AVENTIS U.S. LLC | 4 | $206 |
| Medtronic, Inc. | 9 | $145 |
| Amgen Inc. | 9 | $141 |
Products named: Korlym, ZEPBOUND, DEXCOM G7 GSS (161), Wegovy, MOUNJARO, ISTURISA, FREESTYLE LIBRE 3, TZIELD.
Industry payments across KY — which companies pay providers there.
